These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 20656025

  • 1. Enhanced oral absorption of saquinavir with Methyl-Beta-Cyclodextrin-Preparation and in vitro and in vivo evaluation.
    Pathak SM, Musmade P, Dengle S, Karthik A, Bhat K, Udupa N.
    Eur J Pharm Sci; 2010 Nov 20; 41(3-4):440-51. PubMed ID: 20656025
    [Abstract] [Full Text] [Related]

  • 2. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.
    Arima H, Yunomae K, Hirayama F, Uekama K.
    J Pharmacol Exp Ther; 2001 May 20; 297(2):547-55. PubMed ID: 11303042
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous effect of cyclodextrin complexation, pH, and hydrophilic polymers on naproxen solubilization.
    Cirri M, Maestrelli F, Corti G, Furlanetto S, Mura P.
    J Pharm Biomed Anal; 2006 Sep 11; 42(1):126-31. PubMed ID: 16406448
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of saquinavir after intravenous and oral dosing of saquinavir: hydroxybutenyl-beta-cyclodextrin formulations.
    Buchanan CM, Buchanan NL, Edgar KJ, Little JL, Ramsey MG, Ruble KM, Wacher VJ, Wempe MF.
    Biomacromolecules; 2008 Jan 11; 9(1):305-13. PubMed ID: 18072746
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidine.
    Mady FM, Abou-Taleb AE, Khaled KA, Yamasaki K, Iohara D, Taguchi K, Anraku M, Hirayama F, Uekama K, Otagiri M.
    Int J Pharm; 2010 Sep 15; 397(1-2):1-8. PubMed ID: 20600734
    [Abstract] [Full Text] [Related]

  • 6. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems.
    Ammar HO, Salama HA, Ghorab M, Mahmoud AA.
    Int J Pharm; 2006 Feb 17; 309(1-2):129-38. PubMed ID: 16377107
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evasion of P-gp mediated cellular efflux and permeability enhancement of HIV-protease inhibitor saquinavir by prodrug modification.
    Jain R, Agarwal S, Majumdar S, Zhu X, Pal D, Mitra AK.
    Int J Pharm; 2005 Oct 13; 303(1-2):8-19. PubMed ID: 16137847
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Enhancement of cellular uptake, transport and oral absorption of protease inhibitor saquinavir by nanocrystal formulation.
    He Y, Xia DN, Li QX, Tao JS, Gan Y, Wang C.
    Acta Pharmacol Sin; 2015 Sep 13; 36(9):1151-60. PubMed ID: 26256404
    [Abstract] [Full Text] [Related]

  • 12. In situ study of the effect of naringin, talinolol and protein-energy undernutrition on intestinal absorption of saquinavir in rats.
    Catalán-Latorre A, Nácher A, Merino V, Jiménez-Torres NV, Merino-Sanjuán M.
    Basic Clin Pharmacol Toxicol; 2011 Oct 13; 109(4):245-52. PubMed ID: 21535410
    [Abstract] [Full Text] [Related]

  • 13. Differentiation of gut and hepatic first pass metabolism and secretion of saquinavir in ported rabbits.
    Sinko PJ, Kunta JR, Usansky HH, Perry BA.
    J Pharmacol Exp Ther; 2004 Jul 13; 310(1):359-66. PubMed ID: 15004217
    [Abstract] [Full Text] [Related]

  • 14. Differential roles of P-glycoprotein, multidrug resistance-associated protein 2, and CYP3A on saquinavir oral absorption in Sprague-Dawley rats.
    Usansky HH, Hu P, Sinko PJ.
    Drug Metab Dispos; 2008 May 13; 36(5):863-9. PubMed ID: 18256206
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM, Elkheshen SA, Ghorab MM.
    Eur J Pharm Biopharm; 2008 Nov 13; 70(3):819-27. PubMed ID: 18655829
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intestinal absorption of novel-dipeptide prodrugs of saquinavir in rats.
    Jain R, Duvvuri S, Kansara V, Mandava NK, Mitra AK.
    Int J Pharm; 2007 May 24; 336(2):233-40. PubMed ID: 17207946
    [Abstract] [Full Text] [Related]

  • 19. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats.
    Arima H, Yunomae K, Miyake K, Irie T, Hirayama F, Uekama K.
    J Pharm Sci; 2001 Jun 24; 90(6):690-701. PubMed ID: 11357172
    [Abstract] [Full Text] [Related]

  • 20. Effects of resveratrol on P-glycoprotein and cytochrome P450 3A in vitro and on pharmacokinetics of oral saquinavir in rats.
    Li J, Liu Y, Zhang J, Yu X, Wang X, Zhao L.
    Drug Des Devel Ther; 2016 Jun 24; 10():3699-3706. PubMed ID: 27895462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.